Skip to main content
Premium Trial:

Request an Annual Quote

Japan's Riken Center Chooses Genedata Software for Cancer Biomarker Research

Premium

This story originally ran on Feb. 18.

Japanese research foundation Riken has chosen Genedata's Expressionist software to support biomarker research into cancer, the company said this week.

Riken is using proteomics and mass spectrometry to identify biomarkers for the development of serum-based diagnostics. In a statement, Koki Ueda, a project leader at the Laboratory for Biomarker Development at Riken, said that its proteomics facility generates "huge amounts" of mass spec data. Data analysis has been a "major bottleneck" — particularly for clinical proteomics, where there is a need to quantitatively analyze as many clinical samples as possible due to individual variations.

Genedata Expressionist, Ueda said, "is the only solution we found that can meet our high-throughput needs."

Riken's biomarker development group is using the Refiner MS and Analyst modules from the Genedata Expressionist system for high-throughput LC-MS proteomics data processing and analysis.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.